Simulations to Assess Phase II Noninferiority Trials of Different Doses of Capecitabine in Combination With Docetaxel for Metastatic Breast Cancer

Yazar: Bruno, R, Lindbom, L, Schaedeli Stark, F, Chanu, P, Gilberg, F, Frey, N, Claret, L
Baskı/Yayın Bilgisi 2012

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

Yazar: Cassidy, J, Clarke, S, Díaz-Rubio, E, Scheithauer, W, Figer, A, Wong, R, Koski, S, Rittweger, K, Gilberg, F, Saltz, L
Baskı/Yayın Bilgisi 2011